Amplion, the Bend-based biomarker intelligence company secured their Series A funding from Greycroft with participation from existing investors Revolution’s Rise of the Rest Seed Fund and Imagen Capital Partners. They will use those funds to expand its sales and marketing efforts as well as accelerate product development. Amplion participated in the 2014 Bend Venture Conference and walked away with $400,000 in funding.
Amplion Secured Series A Funding
